BIORA THERAPEUTICS INC: Diferență între versiuni
The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei BIORA THERAPEUTICS INC listata cu simbolurile US.BIOR, US.BIORc, US.PROG ==Descriere companie== Progenity, Inc. is (https://www.progenity.com/) a biotechnology company. The Company is engaged in developing and commercializing molecular testing products in the fields of women's health, gastrointestinal health and oral biotherapeutics. It applies multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to its molecular test...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
Progenity, Inc. is (https://www.progenity.com/) a biotechnology company. The Company is engaged in developing and commercializing molecular testing products in the fields of women's health, gastrointestinal health and oral biotherapeutics. It applies multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to its molecular testing products and to the development of a suite of investigational ingestible devices and drug/device combinations designed to provide precise diagnostic sampling and drug delivery solutions. The Company’s molecular tests are: Innatal Prenatal Screen, Preparent Carrier Test, Riscover Hereditary Cancer Test, and Resura Prenatal Test for Monogenic Disease. The Company is also developing its pipeline products, such as Preecludia pre-eclampsia rule-out test, Drug Delivery System (DDS) platform, and Oral Biopharmaceutical Delivery System (OBDS). It is also developing an ingestible capsule platform designed to help diagnose and treat gastrointestinal (GI) disorders. | Progenity, Inc. is (https://www.progenity.com/) a biotechnology company. The Company is engaged in developing and commercializing molecular testing products in the fields of women's health, gastrointestinal health and oral biotherapeutics. It applies multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to its molecular testing products and to the development of a suite of investigational ingestible devices and drug/device combinations designed to provide precise diagnostic sampling and drug delivery solutions. The Company’s molecular tests are: Innatal Prenatal Screen, Preparent Carrier [[Test]], Riscover Hereditary Cancer Test, and Resura Prenatal Test for Monogenic Disease. The Company is also developing its pipeline products, such as Preecludia pre-eclampsia rule-out test, Drug Delivery System (DDS) platform, and Oral Biopharmaceutical Delivery System (OBDS). It is also developing an ingestible capsule platform designed to help diagnose and treat gastrointestinal (GI) disorders. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||